Medicare Enrolled

Dr. Stephanie Kapsimallis, FNP

Hospice and Palliative Medicine (Internal Medicine) Physician · Fresno, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
2823 FRESNO ST, Fresno, CA 93721
5594596000
In practice since 2013 (12 years)
NPI: 1508202813 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Kapsimallis from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kapsimallis? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Kapsimallis

Dr. Stephanie Kapsimallis is a hospice and palliative medicine physician in Fresno, CA, with 12 years of NPI registration. Based on federal Medicare data, Dr. Kapsimallis performed 736 Medicare services across 321 unique beneficiaries.

Between the years covered by Open Payments, Dr. Kapsimallis received a total of $2,414 from 21 pharmaceutical and/or device companies across 53 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hospice and palliative medicine (internal medicine) physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Kapsimallis is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 12 years in practice ▲ Top 21% volume in CA $2,414 industry payments

Medicare Practice Summary

Medicare Utilization ↗
736
Medicare services
Top 21% in CA for hospice and palliative medicine (internal medicine) physician
321
Unique beneficiaries
$66
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~61 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
444 $52 $198
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
98 $84 $318
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
98 $87 $333
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
50 $81 $297
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
31 $117 $460
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
15 $52 $223
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$2,414
Total received (2021-2024)
Avg $604/year across 4 years
Top 10% in CA for hospice and palliative medicine (internal medicine) physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
21
Companies
53
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,212 (50.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,202 (49.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$714
2023
$585
2022
$981
2021
$135

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Astellas Pharma US Inc
$169
Exelixis Inc.
$115
Alexion Pharmaceuticals, Inc.
$99
Gilead Sciences, Inc.
$84
Novartis Pharmaceuticals Corporation
$77
SERVIER PHARMACEUTICALS LLC
$36
Genentech USA, Inc.
$26
Merck Sharp & Dohme LLC
$24
Janssen Biotech, Inc.
$19
Daiichi Sankyo Inc.
$19
ARRAY BIOPHARMA INC
$17
Celgene Corporation
$16
E.R. Squibb & Sons, L.L.C.
$14
Top 3 companies account for 53.6% of 2024 payments
All-time payments by company (2021-2024) ›
Astellas Pharma US Inc
$526
Alexion Pharmaceuticals, Inc.
$240
Gilead Sciences, Inc.
$209
Lilly USA, LLC
$193
Amgen Inc.
$176
Genentech USA, Inc.
$159
Novartis Pharmaceuticals Corporation
$158
Exelixis Inc.
$132
Takeda Pharmaceuticals U.S.A., Inc.
$111
Janssen Scientific Affairs, LLC
$103
Seagen Inc.
$100
Merck Sharp & Dohme LLC
$51
Celgene Corporation
$40
SERVIER PHARMACEUTICALS LLC
$36
Janssen Biotech, Inc.
$35
TerSera Therapeutics LLC
$30
E.R. Squibb & Sons, L.L.C.
$28
Pharmacosmos Therapeutics Inc.
$24
Sobi, Inc
$24
Daiichi Sankyo Inc.
$19
ARRAY BIOPHARMA INC
$17
Top 3 companies account for 40.4% of all-time payments
Associated products mentioned in payments ›
Blincyto · CABOMETYX · Columvi · DARZALEX · DOPTELET · ERLEADA · Fabhalta · ICLUSIG · INJECTAFER · KEYTRUDA · KISQALI · Kyprolis · LUMAKRAS · MEKINIST · MONOFERRIC · PADCEV · PROMACTA · Polivy · REBLOZYL · RYBREVANT · SCEMBLIX · SOLIRIS · TECENTRIQ · Trodelvy · ULTOMIRIS · VERZENIO · Voranigo · XALKORI · Xermelo · Xospata
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (50%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in hospice and palliative medicine (internal medicine) physician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 10% for hospice and palliative medicine (internal medicine) physician in CA.

Looking for a hospice and palliative medicine physician in Fresno?
Compare hospice and palliative medicine physicians in the Fresno area by procedure volume, costs, and industry payment transparency.
Browse hospice and palliative medicine physicians nearby

Geographic Context

Hospice and palliative medicine physicians within 10 mi
5
Per 100K population
0.5
County median income
$71,434
Nearest hospital
COMMUNITY REGIONAL MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Kapsimallis is a clinical cardiology specialist, with above-average Medicare volume (top 21% in CA), with speaking/promotional industry engagement in the top 10% of CA peers.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Kapsimallis experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Kapsimallis performed 444 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kapsimallis receive payments from pharmaceutical companies?
Yes. Dr. Kapsimallis received a total of $2,414 from 21 companies across 53 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kapsimallis's costs compare to other hospice and palliative medicine physicians in Fresno?
Dr. Kapsimallis's average Medicare payment per service is $66. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kapsimallis) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →